Ashland’s highly qualified nominees have expertise critical to its business Company illustrates commitment to board refreshment and working constructively with […]
YONKERS, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]